Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

4.180 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agenus Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Down 75%. Is Agenus Stock a Buy on the Dip?
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher. 
Via The Motley Fool
RADCOM, Lotus Technology And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Agenus Announces Reverse Stock Split of Common Stock
From Agenus Inc.
Via Business Wire
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
These stocks could rocket higher, but they also present significant risks. 
Via The Motley Fool
Earnings Preview For Agenus
 
Via Benzinga
Agenus's Earnings Outlook
 
Via Benzinga
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
If you want the chance at possible absurd returns, then consider gambling on these stocks to turn $1,000 into $1 million. 
Via InvestorPlace
Agenus (AGEN) Q4 2023 Earnings Call Transcript
AGEN earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Agenus Reports Fourth Quarter and Full Year 2023 Results
From Agenus Inc.
Via Business Wire
Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
From Agenus Inc.
Via Business Wire
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Agenus Inc.
Via Business Wire
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
From Agenus Inc.
Via Business Wire
Agenus to Participate in Leerink Partners Global Biopharma Conference
From Agenus Inc.
Via Business Wire
Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today
The company hopes to engineer a 1-for-20 reverse stock split. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot. 
Via InvestorPlace
Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
From Agenus Inc.
Via Business Wire
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains 
Via InvestorPlace
Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
From Agenus Inc.
Via Business Wire
Why LQR House Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Shares of LQR House Inc. (NASDAQ: LQR) rose sharply in pre-market trading. Borg's investor group has acquired a 20% stake in LQR House. LQR House shares jumped 16.1% to $4.25 in pre-market trading Here... 
Via Benzinga
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Agenus Inc.
Via Business Wire
Agenus to Participate in B. Riley Healthcare Conference
From Agenus Inc.
Via Business Wire
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
These two biotech stocks could be poised for a trend reversal. 
Via The Motley Fool
Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024
From Agenus Inc.
Via Business Wire
Agenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific Program
From Agenus Inc.
Via Business Wire
Agenus Reports Third Quarter 2023 Results
From Agenus Inc.
Via Business Wire
Agenus to Provide Third Quarter 2023 Financial Report and Corporate Update
From Agenus Inc.
Via Business Wire
Textainer Group, Roivant Sciences And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures traded lower this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Agenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma
From Agenus Inc.
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.